Gossamer Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	41.03	37.73	46.07	32.11	111.97	183.4
Short-Term Investments	58.19	99.2	248.44	264.32	143.71	141.82
Cash & Short-Term Investments	99.22	136.93	294.52	296.43	255.68	325.22
Cash Growth	-61.53%	-53.51%	-0.64%	15.94%	-21.38%	-36.56%
Other Receivables	9.25	12.23	5.34	-	-	-
Total Trade Receivables	9.25	12.23	5.34	-	-	-
Other Current Assets	16.07	18.49	10.03	10.09	6.2	6.56
Total Current Assets	124.54	167.64	309.89	306.52	261.88	331.78
Net Property, Plant & Equipment	3.97	4.2	5.12	4.78	9.89	10.8
Other Long-Term Assets	0.4	0.41	0.28	0.62	0.68	1.08
Total Assets	128.9	172.25	315.29	311.92	272.45	343.66
Accounts Payable	10.82	5.96	2.32	5.53	1.46	3.24
Accrued Expenses	36.94	37.49	25.64	34.46	36.16	36.62
Current Portion of Long-Term Debt	-	-	-	11.61	11.61	-
Unearned Revenue	8.74	19.99	17.05	-	-	-
Total Current Liabilities	56.51	63.44	45.01	51.6	49.23	39.86
Long-Term Debt	198.76	198.51	197.52	197.41	207.7	179.12
Long-Term Leases	3.21	3.46	4.4	0.14	3.45	3.22
Other Long-Term Liabilities	31.9	29.61	38.87	-	-	-
Total Long-Term Liabilities	233.88	231.57	240.79	197.55	211.14	182.34
Total Liabilities	290.38	295.01	285.8	249.15	260.37	222.19
Common Stock	0.02	0.02	0.02	0.02	0.01	0.01
Additional Paid-in Capital	1,328	1,321	1,297	1,275	1,045	932.94
Accumulated Other Comprehensive Income	-4.02	-5.15	1.19	-0.35	-0.57	0.05
Retained Earnings	-1,486	-1,439	-1,269	-1,212	-1,032	-811.53
Shareholders' Equity	-161.48	-122.76	29.49	62.77	12.08	121.46
Total Liabilities & Equity	128.9	172.25	315.29	311.92	272.45	343.66
Total Debt	201.98	201.97	201.92	209.16	222.76	182.34
Net Cash (Debt)	-102.76	-65.04	92.6	87.26	32.92	142.88
Net Cash Growth	-	-	6.11%	165.06%	-76.96%	-57.03%
Net Cash Per Share	-0.45	-0.28	0.41	0.57	0.39	1.91
Book Value	-161.48	-122.76	29.49	62.77	12.08	121.46
Book Value Per Share	-0.71	-0.54	0.13	0.41	0.14	1.62
Tangible Book Value	-161.48	-122.76	29.49	62.77	12.08	121.46
Tangible Book Value Per Share	-0.71	-0.54	0.13	0.41	0.14	1.62

SEC Filings: 10-K · 10-Q